DiaMedica Therapeutics Inc.
DMAC
$5.67
-$0.13-2.24%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.27M | -5.12M | -5.15M | -5.16M | -4.47M |
| Total Depreciation and Amortization | 10.00K | 10.00K | 8.00K | 8.00K | 8.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 219.00K | 143.00K | 177.00K | 107.00K | 19.00K |
| Change in Net Operating Assets | 1.58M | 447.00K | -1.69M | 1.23M | -353.00K |
| Cash from Operations | -4.47M | -4.52M | -6.65M | -3.81M | -4.80M |
| Capital Expenditure | -9.00K | 0.00 | -9.00K | -3.00K | -10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.58M | 4.74M | 4.22M | 6.13M | 1.21M |
| Cash from Investing | -5.59M | 4.74M | 4.21M | 6.12M | 1.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.00K | -2.00K | -1.00K | -1.00K | -2.00K |
| Issuance of Common Stock | 126.00K | 11.75M | -- | 0.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -4.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 123.00K | 11.75M | -1.00K | -1.00K | -6.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.93M | 11.97M | -2.45M | 2.31M | -3.61M |
